DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--IMV to Host Key Opinion Leader Symposium on Role of Survivin in Cancer Biology and Potential of DPX-Survivac
QUEBEC--(BUSINESS WIRE)--Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced today that Dr. André P. Boulet, president and CEO and Dr. Nathalie Boucher, Director Research of the Corporation, will present at the World Conference on Ageing and Gerontology, which is being held in Lisbon, Portugal from August 10-11, 2
VANCOUVER, Canada--(BUSINESS WIRE)--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics (“Zymeworks” or the “Company”), announced today the pricing of its previously-announced underwritten public offering (the “Offering”) of 4,924,729 common shares and, in lieu of common shares to a certain investor, pre-funded warrants to purchase up to 1,075,271 common shares. The common shares are being offered at a price to the public of US$46.5
VANCOUVER, British Columbia---(BUSINESS WIRE)--Zymeworks Inc. (NYSE: ZYME) (“Zymeworks” or the “Company”), a clinical‑stage biopharmaceutical company developing multifunctional biotherapeutics, has today filed a preliminary prospectus supplement (the “Canadian Supplement”) to its Canadian short form base shelf prospectus dated November 18, 2019 (the “Base Prospectus”) in connection with an offering of its common shares and, in lieu of common shares to a certain investor, pre-funded warrants to
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) is proud to be named in the Corporate Knights Global 100 Most Sustainable Corporations in the World (Global 100) for the fifth consecutive year. Corporate Knights assesses more than 7,300 companies against 21 key performance indicators. It uses these indicators to determine the top 1% most sustainable companies in the world, which are announced annually at the World Economic Forum in Davos, Swi
TORONTO--(BUSINESS WIRE)--Halo Labs Inc. (“Halo” or the “Company”) (OTCQX:AGEEF), wishes to make the following statements regarding recent market activity concerning its common shares (the “Common Shares”) traded on the OTCQX marketplace. The Company became aware of certain promotional activity on its securities on January 14, 2020 when it received correspondence from OTC Markets. The Company has no knowledge of any promotional activity other than its understanding that there appears to have be
